Chemical Compound
Pioglitazone Hydrochloride Imp. C (EP); Pioglitazone Imp. C (EP); (5RS)-5-[4-[2-(5-Ethylpyridin-2-yl)ethoxy]benzyl]-3-[2-(5-ethylpyridin-2-yl)ethyl]-1,3-thiazolidine-2,4-dione; Pioglitazone Hydrochloride Imp. C (Pharmeuropa); Pioglitazone Hydrochloride Impurity C; Pioglitazone Impurity C
CAS Registry Number
952188-00-0
Primary record
Pioglitazone Hydrochloride Imp. C (EP); Pioglitazone Imp. C (EP); (5RS)-5-[4-[2-(5-Ethylpyridin-2-yl)ethoxy]benzyl]-3-[2-(5-ethylpyridin-2-yl)ethyl]-1,3-thiazolidine-2,4-dione; Pioglitazone Hydrochloride Imp. C (Pharmeuropa); Pioglitazone Hydrochloride Impurity C; Pioglitazone Impurity C
- 库存
- 2,454 克
- 纯度
- 98.6 %
- CAS
- 952188-00-0
化合物标识与属性
- CAS
- 952188-00-0
- PubChem CID
- 17756229
- SMILES
- CCC1=CN=C(C=C1)CCN2C(=O)C(SC2=O)CC3=CC=C(C=C3)OCCC4=NC=C(C=C4)CC
- Canonical SMILES
- CCc1ccc(CCOc2ccc(CC3SC(=O)N(CCc4ccc(CC)cn4)C3=O)cc2)nc1
名称与同义词
- 952188-00-0
- UNII-0A40W8CWPF
- Pioglitazone Impurity
- PIOGLITAZONE EP IMPURITY C
- 0A40W8CWPF
- Pioglitazone Impurity C
- RefChem:202037
- (Pioglitazone Impurity)"
- N-(Ethyl-(2-pyridyl-5-ethyl)) pioglitazone
- PIOGLITAZONEEPIMPURITYC
- N-[Ethyl-(2-pyridyl-5-ethyl) Pioglitazone(Pioglitazone Impurity)
- SCHEMBL4181113
- C28H31N3O3S
- CTK8E7570
- MFCD18252638
- AKOS030255511
- IE23077
- N-[Ethyl-(2-pyridyl-5-ethyl) Pioglitazone
- 4-[2- ethoxy]benzenepropanoicAcidEthylEster
- Pioglitazone hydrochloride specified impurity C [EP]
- RT-014603
- FT-0668388
- J3.374.149I
- Pioglitazone hydrochloride specified impurity C
- 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-3-[2-(5-ethylpyridin-2-yl)ethyl]-1,3-thiazolidine-2,4-dione
- PIOGLITAZONE HYDROCHLORIDE IMPURITY C [EP IMPURITY]
- N-[[6-(trifluoromethyl)pyridin-2-yl]methyl]ethanamine
- Q27236522
- (5RS)-5-((4-(2-(5-Ethylpyridin-2-yl)ethoxy)phenyl)methyl)-3-(2-(5-ethylpyridin-2-yl)ethyl)thiazolidine-2,4-dione
- 2,4-Thiazolidinedione, 5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-3-(2-(5-ethyl-2-pyridinyl)ethyl)-
- Pioglitazone hydrochloride impurity, N-alkylpioglitazone- [USP]
- PIOGLITAZONE HYDROCHLORIDE IMPURITY C (EP IMPURITY)
- (+/-)-5-(4-(2-(5-Ethylpyridin-2-yl)ethoxy)benzyl)-3-(2-(5-ethylpyridin-2-yl)ethyl)thiazolidine-2,4-dione
- 5-(4-(2-(5-ethylpyridin-2-yl)ethoxy)benzyl)-3-(2-(5-ethylpyridin-2-yl)ethyl)thiazolidine-2,4-dione
- ethyl 3-[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]propanoate
- Pioglitazone hydrochloride impurity, N-alkylpioglitazone-(USP)
- Pioglitazone hydrochloride impurity, N-alkylpioglitazone-[USP]
- (5RS)-5-[[4-[2-(5-Ethylpyridin-2-yl)ethoxy]phenyl]methyl]-3-[2-(5-ethylpyridin-2-yl)ethyl]thiazolidine-2,4-dione
- 5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-3-[2-(5-ethyl-2-pyridinyl)ethyl]-2,4-thiazolidinedione
- 868754-42-1
- PIOGLITAZONE HYDROCHLORIDE IMPURITY, N-ALKYLPIOGLITAZONE- [USP IMPURITY]
- PIOGLITAZONE HYDROCHLORIDE IMPURITY, N-ALKYLPIOGLITAZONE-(USP IMPURITY)
- PIOGLITAZONE HYDROCHLORIDE IMPURITY, N-ALKYLPIOGLITAZONE-[USP IMPURITY]
- (+-)-5-(4-(2-(5-ETHYLPYRIDIN-2-YL)ETHOXY)BENZYL)-3-(2-(5-ETHYLPYRIDIN-2-YL)ETHYL)THIAZOLIDINE-2,4-DIONE
- (5RS)-5-[[4-[2-(5-Ethylpyridin-2-yl)ethoxy]-phenyl]methyl]-3-[2-(5-ethylpyridin-2-yl)-ethyl]thiazolidine-2,4-dione
- 5-({4-[2-(5-ETHYLPYRIDIN-2-YL)ETHOXY]PHENYL}METHYL)-3-[2-(5-ETHYLPYRIDIN-2-YL)ETHYL]-1,3-THIAZOLIDINE-2,4-DIONE
- 5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-N-[2-(5-ethylpyridin-2-yl)ethyl]-2,4-thiazolidinedione
- 5-[[4-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl]methyl]-3-[2-(5-ethyl-2-pyridyl)ethyl]thiazolidine-2,4-dione
- 5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]-3-[2-(5-ethyl-2-pyridyl)ethyl]thiazolidine-2,4-dione
- 5-[4-[2-(5-Ethylpyridin-2-yl)ethoxy]benzyl]-3-[2-(5-ethylpyridin-2-yl)ethyl]thiazolidine-2,4-dione
- 952195-06-1
- N/A
- Pioglitazone Hydrochloride Imp. C (EP); Pioglitazone Imp. C (EP); (5RS)-5-[4-[2-(5-Ethylpyridin-2-yl)ethoxy]benzyl]-3-[2-(5-ethylpyridin-2-yl)ethyl]-1,3-thiazolidine-2,4-dione; Pioglitazone Hydrochloride Imp. C (Pharmeuropa); Pioglitazone Hydrochloride Impurity C; Pioglitazone Impurity C